Non-methylated CpG-motifs in bacterial or viral DNA are recognized by TLR9 as foreign. The activation of TLR9 by microbial DNA or synthetic oligonucleotides based on these motifs leads to the induction of innate immune responses. We have compared the subcellular localization of fluorescent versions of TLR9 and TLR4 and found that TLR9 is expressed in the endoplasmic reticulum while TLR4 is expressed on the plasma membrane. Fluorescently tagged bacterial DNA or CpG-DNA was observed to traffic to a tubular lysosomal compartment in human pDCs. In stimulated cells, TLR9 translocated to CpG-DNA or microbial DNA containing structures in the endosome, where TLR9 binds to DNA and initiates signaling.
Janeway Jr CAThe immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today1992; 13: 11—16.
2.
Rock FL, Hardiman G., Timans JC, Kastelein RA, Bazan JFA family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA1998; 95: 588—593.
3.
Takeda K., Kaisho T., Akira S.Toll-like receptors. Annu Rev Immunol2003 ; 21: 335—376.
4.
Matzinger P.An innate sense of danger. Semin Immunol1998; 10: 399—415.
5.
Krieg AM, Yi AK, Matson S. et al. CpG motifs in bacterial DNA trigger direct B-cell activation . Nature1995; 374: 546—549.
6.
Hemmi H., Takeuchi O., Kawai T. et al. A Toll-like receptor recognizes bacterial DNA. Nature2000; 408: 740—745.
7.
Heil F., Hemmi H., Hochrein H. et al. Species-specific recognition of single-stranded RNA via Toll-like receptors 7 and 8. Science2004; 303: 1526—1529.
8.
Krieg AMCpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol2002; 20: 709—760.
9.
Hartmann G., Weiner GJ, Krieg AMCpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA1999; 96: 9305—9310.
10.
Hartmann G. , Battiany J., Poeck H. et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol2003; 33: 1633—1641.
11.
Krug A., Rothenfusser S., Hornung V. et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol2001; 31: 2154—2163.
12.
Gursel M., Verthelyi D., Gursel I., Ishii KJ, Klinman DMDifferential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukoc Biol2002; 71: 813—820.
13.
Jones PA, Takai D.The role of DNA methylation in mammalian epigenetics. Science2001; 293: 1068—1070.
14.
Bird AP, Taggart MH, Nicholls RD, Higgs DRNon-methylated CpG-rich islands at the human alpha-globin locus: implications for evolution of the alpha-globin pseudogene. EMBO J1987; 6: 999—1004.
15.
Okano M., Bell DW, Haber DA, Li E.DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell1999; 99: 247—257.
16.
Pfeifer GP, Tanguay RL, Steigerwald SD, Riggs ADIn vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. Genes Dev1990; 4: 1277—1287.
17.
Baylin SB, Herman JGDNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet2000; 16: 168—174.
18.
Fitzpatrick DR, Wilson CBMethylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol2003; 109: 37—45.
19.
Krapf F., Herrmann M., Leitmann W., Kalden JRAntibody binding of macromolecular DNA and RNA in the plasma of SLE patients . Clin Exp Immunol1989; 75: 336—342.
20.
Sano H., Takai O., Harata N., Yoshinaga K., Kodama-Kamada I., Sasaki T.Binding properties of human anti-DNA antibodies to cloned human DNA fragments . Scand J Immunol1989; 30: 51—63.
21.
Sano H., Imokawa M., Steinberg AD, Morimoto C.Accumulation of guanine-cytosine-enriched low M.W. DNA fragments in lymphocytes of patients with systemic lupus erythematosus. J Immunol1983; 130: 187—190.
22.
Leadbetter EA , Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A.Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature2002; 416: 603—607.
23.
Rifkin IR, Leadbetter EA, Beaudette BC et al. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells. J Immunol2000; 165: 1626—1633.
24.
Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A.Activation of autoreactive B cells by CpG dsDNA. Immunity2003; 19: 837—847.
25.
Leadbetter EA , Rifkin IR, Marshak-Rothstein A.Toll-like receptors and activation of autoreactive B cells. Curr Dir Autoimmun2003; 6: 105—122.
26.
Boule MW, Broughton C., Mackay F., Akira S., Marshak-Rothstein A., Rifkin IRToll-like receptor 9-dependent and -independent dendritic cell activation by chromatin—immunoglobulin G complexes. J Exp Med2004; 199: 1631—1640.
27.
Sandor F., Latz E., Re F. et al. Importance of extra- and intracellular domains of TLR1 and TLR2 in NF-kappa B signaling. J Cell Biol2003; 162: 1099—1110.
28.
Heil F., Ahmad-Nejad P., Hemmi H. et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol2003; 33: 2987—2997.
29.
Latz E., Schoenemeyer A., Visintin A. et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol2004; 5: 190—198.
30.
Latz E., Visintin A., Lien E. et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem2002; 277: 47834—47843.
31.
Latz E., Visintin A., Lien E., Fitzgerald KA, Espevik T., Golenbock DTThe LPS receptor generates inflammatory signals from the cell surface. J Endotoxin Res2003; 9: 375—380.
32.
Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas RM, Wagner H.Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol2002; 32: 1958—1968.
33.
Chow A., Toomre D., Garrett W., Mellman I.Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature2002 ; 418: 988—994.
34.
Boes M., Cerny J., Massol R. et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature2002; 418: 983—988.
35.
Hacker H., Mischak H., Miethke T. et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J1998; 17: 6230—6240.
36.
Garin J., Diez R., Kieffer S. et al. The phagosome proteome: insight into phagosome functions. J Cell Biol2001; 152: 165—180.
37.
Gagnon E., Duclos S., Rondeau C. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell2002; 110: 119—131.
38.
Houde M., Bertholet S., Gagnon E. et al. Phagosomes are competent organelles for antigen cross-presentation . Nature2003; 425: 402—406.
39.
Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P, Amigorena S.ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature2003; 425: 397—402.
Ackermann ML , Cresswell P.Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol2004; 5: 678—684.
42.
Verthelyi D. , Ishii KJ, Gursel M., Takeshita F., Klinman DMHuman peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol2001; 166: 2372—2377.
43.
Krieg AMFrom bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA. Antisense Nucleic Acid Drug Dev2001; 11: 181—188.
44.
Krieg AMAntitumor applications of stimulating Toll-like receptor 9 with CpG oligodeoxynucleotides . Curr Oncol Report2004; 6: 88—95.
45.
Klinman DMUse of CpG oligodeoxynucleotides as immunoprotective agents. Expert Opin Biol Ther2004; 4: 937—946.
